GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED

Active Stevenage

Activities of other holding companies n.e.c.

0 employees website.com
Activities of other holding companies n.e.c.
G

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED

Activities of other holding companies n.e.c.

Founded 6 Nov 2012 Active Stevenage, United Kingdom 0 employees website.com
Activities of other holding companies n.e.c.
Accounts Submitted 15 Aug 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 22 Sept 2025 Next due 6 Oct 2026 3 months remaining
Net assets £900M £195M 2024 year on year
Total assets £1,223M £159M 2024 year on year
Total Liabilities £323M £37M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Gsk Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY United Kingdom

Full company profile for GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (08283252), an active company based in Stevenage, United Kingdom. Incorporated 6 Nov 2012. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£899.90M

Increased by £195.22M (+28%)

Total Liabilities

£323.43M

Decreased by £36.53M (-10%)

Turnover

£1021.52M

Increased by £6.57M (+1%)

Employees

N/A

Debt Ratio

26%

Decreased by 8 (-24%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Edinburgh Pharmaceutical Industries LimitedCorporate-directorUnited KingdomUnknown6 Nov 2012Active

Shareholders

Shareholders (1)

Glaxosmithkline Intellectual Property Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Sept 2025Confirmation StatementConfirmation statement made on 22 Sept 2025 with no updates
15 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
31 Jul 2025OfficersChange Corporate Secretary Company With Change Date
31 Jul 2025OfficersChange Corporate Director Company With Change Date
16 Jul 2025OfficersAppointment of Mrs Anna Mary Harcourt Fent as director on 10 Jul 2025
22 Sept 2025 Confirmation Statement

Confirmation statement made on 22 Sept 2025 with no updates

15 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

31 Jul 2025 Officers

Change Corporate Secretary Company With Change Date

31 Jul 2025 Officers

Change Corporate Director Company With Change Date

16 Jul 2025 Officers

Appointment of Mrs Anna Mary Harcourt Fent as director on 10 Jul 2025

Recent Activity

Latest Activity

Confirmation statement made on 22 Sept 2025 with no updates

8 months ago on 22 Sept 2025

Annual accounts made up to 31 Dec 2024

10 months ago on 15 Aug 2025

Change Corporate Secretary Company With Change Date

10 months ago on 31 Jul 2025

Change Corporate Director Company With Change Date

10 months ago on 31 Jul 2025

Appointment of Mrs Anna Mary Harcourt Fent as director on 10 Jul 2025

11 months ago on 16 Jul 2025